Utah Medical Products Pre-Tax Profit Margin 2012-2025 | UTMD
Utah Medical Products pre-tax profit margin from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Utah Medical Products Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $0.04B | $0.02B | 38.46% |
| 2025-06-30 | $0.04B | $0.02B | 41.03% |
| 2025-03-31 | $0.04B | $0.02B | 41.03% |
| 2024-12-31 | $0.04B | $0.02B | 42.50% |
| 2024-09-30 | $0.04B | $0.02B | 41.86% |
| 2024-06-30 | $0.05B | $0.02B | 41.30% |
| 2024-03-31 | $0.05B | $0.02B | 40.82% |
| 2023-12-31 | $0.05B | $0.02B | 39.22% |
| 2023-09-30 | $0.05B | $0.02B | 39.62% |
| 2023-06-30 | $0.05B | $0.02B | 39.62% |
| 2023-03-31 | $0.05B | $0.02B | 39.62% |
| 2022-12-31 | $0.05B | $0.02B | 40.38% |
| 2022-09-30 | $0.05B | $0.02B | 39.22% |
| 2022-06-30 | $0.05B | $0.02B | 39.22% |
| 2022-03-31 | $0.05B | $0.02B | 39.22% |
| 2021-12-31 | $0.05B | $0.02B | 38.00% |
| 2021-09-30 | $0.05B | $0.02B | 36.73% |
| 2021-06-30 | $0.05B | $0.02B | 36.96% |
| 2021-03-31 | $0.04B | $0.01B | 33.33% |
| 2020-12-31 | $0.04B | $0.01B | 33.33% |
| 2020-09-30 | $0.04B | $0.02B | 35.71% |
| 2020-06-30 | $0.04B | $0.02B | 34.09% |
| 2020-03-31 | $0.05B | $0.02B | 38.30% |
| 2019-12-31 | $0.05B | $0.02B | 38.30% |
| 2019-09-30 | $0.05B | $0.02B | 37.78% |
| 2019-06-30 | $0.04B | $0.02B | 39.53% |
| 2019-03-31 | $0.04B | $0.02B | 42.86% |
| 2018-12-31 | $0.04B | $0.02B | 45.24% |
| 2018-09-30 | $0.04B | $0.02B | 47.62% |
| 2018-06-30 | $0.04B | $0.02B | 50.00% |
| 2018-03-31 | $0.04B | $0.02B | 47.62% |
| 2017-12-31 | $0.04B | $0.02B | 48.78% |
| 2017-09-30 | $0.04B | $0.02B | 47.50% |
| 2017-06-30 | $0.04B | $0.02B | 45.00% |
| 2017-03-31 | $0.04B | $0.02B | 43.59% |
| 2016-12-31 | $0.04B | $0.02B | 41.03% |
| 2016-09-30 | $0.04B | $0.02B | 40.00% |
| 2016-06-30 | $0.04B | $0.02B | 40.00% |
| 2016-03-31 | $0.04B | $0.02B | 40.00% |
| 2015-12-31 | $0.04B | $0.02B | 40.00% |
| 2015-09-30 | $0.04B | $0.02B | 40.00% |
| 2015-06-30 | $0.04B | $0.02B | 39.02% |
| 2015-03-31 | $0.04B | $0.02B | 39.02% |
| 2014-12-31 | $0.04B | $0.02B | 39.02% |
| 2014-09-30 | $0.04B | $0.02B | 36.59% |
| 2014-06-30 | $0.04B | $0.02B | 37.50% |
| 2014-03-31 | $0.04B | $0.02B | 37.50% |
| 2013-12-31 | $0.04B | $0.02B | 37.50% |
| 2013-09-30 | $0.04B | $0.02B | 37.50% |
| 2013-06-30 | $0.04B | $0.02B | 37.50% |
| 2013-03-31 | $0.04B | $0.01B | 35.00% |
| 2012-12-31 | $0.04B | $0.01B | 34.15% |
| 2012-09-30 | $0.04B | $0.01B | 34.15% |
| 2012-06-30 | $0.04B | $0.01B | 30.95% |
| 2012-03-31 | $0.04B | $0.01B | 30.95% |
| 2011-12-31 | $0.04B | $0.01B | 28.95% |
| 2011-09-30 | $0.03B | $0.01B | 29.41% |
| 2011-06-30 | $0.03B | $0.01B | 31.03% |
| 2011-03-31 | $0.03B | $0.01B | 32.00% |
| 2010-12-31 | $0.02B | $0.01B | 33.33% |
| 2010-09-30 | $0.02B | $0.01B | 33.33% |
| 2010-06-30 | $0.03B | $0.01B | 32.00% |
| 2010-03-31 | $0.03B | $0.01B | 32.00% |
| 2009-12-31 | $0.03B | $0.01B | 32.00% |
| 2009-09-30 | $0.03B | $0.01B | 30.77% |
| 2009-06-30 | $0.03B | $0.01B | 34.62% |
| 2009-03-31 | $0.03B | $0.01B | 37.04% |
| 2008-12-31 | $0.03B | $0.01B | 39.29% |
| 2008-09-30 | $0.03B | $0.01B | 42.86% |
| 2008-06-30 | $0.03B | $0.01B | 42.86% |
| 2008-03-31 | $0.03B | $0.01B | 42.86% |
| 2007-12-31 | $0.03B | $0.01B | 42.86% |
| 2007-09-30 | $0.03B | $0.01B | 42.86% |
| 2007-06-30 | $0.03B | $0.01B | 42.86% |
| 2007-03-31 | $0.03B | $0.01B | 42.86% |
| 2006-12-31 | $0.03B | $0.01B | 42.86% |
| 2006-09-30 | $0.03B | $0.01B | 39.29% |
| 2006-06-30 | $0.03B | $0.01B | 35.71% |
| 2006-03-31 | $0.03B | $0.01B | 35.71% |
| 2005-12-31 | $0.03B | $0.01B | 35.71% |
| 2005-09-30 | $0.03B | $0.02B | 59.26% |
| 2005-06-30 | $0.03B | $0.02B | 62.96% |
| 2005-03-31 | $0.03B | $0.02B | 62.96% |
| 2004-12-31 | $0.03B | $0.02B | 62.96% |
| 2004-09-30 | $0.03B | $0.03B | 121.43% |
| 2004-06-30 | $0.03B | $0.03B | 121.43% |
| 2004-03-31 | $0.03B | $0.03B | 121.43% |
| 2003-12-31 | $0.03B | $0.03B | 121.43% |
| 2003-09-30 | $0.03B | $0.01B | 42.86% |
| 2003-06-30 | $0.03B | $0.01B | 42.86% |
| 2003-03-31 | $0.03B | $0.01B | 42.86% |
| 2002-12-31 | $0.03B | $0.01B | 42.86% |
| 2002-09-30 | $0.03B | $0.01B | 39.29% |
| 2002-06-30 | $0.03B | $0.01B | 35.71% |
| 2002-03-31 | $0.03B | $0.01B | 32.14% |
| 2001-12-31 | $0.03B | $0.01B | 28.57% |
| 2001-09-30 | $0.03B | $0.01B | 28.57% |
| 2001-06-30 | $0.03B | $0.01B | 28.57% |
| 2001-03-31 | $0.03B | $0.01B | 28.57% |
| 2000-12-31 | $0.03B | $0.01B | 28.57% |
| 2000-09-30 | $0.03B | $0.01B | 27.59% |
| 2000-06-30 | $0.03B | $0.01B | 26.67% |
| 2000-03-31 | $0.03B | $0.01B | 26.67% |
| 1999-12-31 | $0.03B | $0.01B | 26.67% |
| 1999-09-30 | $0.03B | $0.01B | 27.59% |
| 1999-06-30 | $0.03B | $0.01B | 28.57% |
| 1999-03-31 | $0.03B | $0.01B | 28.57% |
| 1998-12-31 | $0.03B | $0.01B | 29.63% |
| 1998-09-30 | $0.03B | $0.01B | 48.15% |
| 1998-06-30 | $0.03B | $0.01B | 48.15% |
| 1998-03-31 | $0.03B | $0.02B | 64.00% |
| 1997-12-31 | $0.02B | $0.02B | 79.17% |
| 1997-09-30 | $0.03B | $0.02B | 57.69% |
| 1997-06-30 | $0.03B | $0.02B | 55.17% |
| 1997-03-31 | $0.03B | $0.02B | 61.76% |
| 1996-12-31 | $0.04B | $0.02B | 51.28% |
| 1996-09-30 | $0.04B | $0.02B | 51.22% |
| 1996-06-30 | $0.04B | $0.02B | 50.00% |
| 1996-03-31 | $0.04B | $0.01B | 32.56% |
| 1995-12-31 | $0.04B | $0.01B | 30.23% |
| 1995-09-30 | $0.04B | $0.01B | 28.57% |
| 1995-06-30 | $0.04B | $0.01B | 29.27% |
| 1995-03-31 | $0.04B | $0.01B | 30.00% |
| 1994-12-31 | $0.04B | $0.01B | 30.77% |
| 1994-09-30 | $0.04B | $0.01B | 28.95% |
| 1994-06-30 | $0.04B | $0.01B | 29.73% |
| 1994-03-31 | $0.04B | $0.01B | 30.56% |
| 1993-12-31 | $0.04B | $0.01B | 30.56% |
| 1993-09-30 | $0.04B | $0.01B | 32.43% |
| 1993-06-30 | $0.04B | $0.01B | 32.43% |
| 1993-03-31 | $0.04B | $0.01B | 29.73% |
| 1992-12-31 | $0.04B | $0.01B | 27.78% |
| 1992-09-30 | $0.03B | $0.01B | 26.47% |
| 1992-06-30 | $0.03B | $0.01B | 24.24% |
| 1992-03-31 | $0.03B | $0.01B | 25.81% |
| 1991-12-31 | $0.03B | $0.01B | 26.67% |
| 1991-09-30 | $0.03B | $0.01B | 27.59% |
| 1991-06-30 | $0.03B | $0.01B | 29.63% |
| 1991-03-31 | $0.03B | $0.01B | 28.00% |
| 1990-12-31 | $0.02B | $0.01B | 26.09% |
| 1990-09-30 | $0.02B | $0.01B | 23.81% |
| 1990-06-30 | $0.02B | $0.00B | 20.00% |
| 1990-03-31 | $0.02B | $0.00B | 21.05% |
| 1989-12-31 | $0.02B | $0.00B | 22.22% |
| 1989-09-30 | $0.02B | $0.00B | 23.53% |
| 1989-06-30 | $0.02B | $0.00B | 26.67% |
| 1989-03-31 | $0.01B | $0.00B | 21.43% |
| 1988-12-31 | $0.01B | $0.00B | 16.67% |
| 1988-09-30 | $0.01B | $0.00B | 10.00% |
| 1988-06-30 | $0.01B | 0 | 0.00% |
| 1988-03-31 | $0.01B | 0 | 0.00% |
| 1987-12-31 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.200B | $0.039B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.137B | 21.57 |
| EssilorLuxottica (ESLOY) | France | $140.784B | 0.00 |
| Stryker (SYK) | United States | $136.173B | 26.12 |
| Medtronic (MDT) | Ireland | $130.317B | 18.06 |
| Boston Scientific (BSX) | United States | $109.879B | 24.30 |
| Medline (MDLN) | United States | $62.231B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.151B | 0.00 |
| ResMed (RMD) | United States | $40.201B | 26.84 |
| Agilent Technologies (A) | United States | $36.062B | 22.85 |
| GE HealthCare Technologies (GEHC) | United States | $36.041B | 17.27 |
| Koninklijke Philips (PHG) | Netherlands | $28.522B | 18.63 |
| Terumo (TRUMY) | Japan | $19.692B | 22.25 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.783B | 11.09 |
| Insulet (PODD) | United States | $17.275B | 53.62 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.896B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.955B | 28.60 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.828B | 24.47 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 13.17 |
| BillionToOne (BLLN) | United States | $4.229B | 0.00 |
| ICU Medical (ICUI) | United States | $3.749B | 23.80 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.092B | 14.59 |
| Haemonetics (HAE) | United States | $2.681B | 11.73 |
| Neogen (NEOG) | United States | $2.308B | 50.52 |
| Phibro Animal Health (PAHC) | United States | $2.102B | 18.52 |
| QuidelOrtho (QDEL) | United States | $1.988B | 12.78 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.963B | 39.52 |
| AtriCure (ATRC) | United States | $1.836B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.672B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.564B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| AdaptHealth (AHCO) | United States | $1.452B | 21.02 |
| Capricor Therapeutics (CAPR) | United States | $1.152B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.092B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.090B | 323.29 |
| InMode (INMD) | Israel | $0.956B | 10.80 |
| Tilray Brands (TLRY) | Canada | $0.897B | 0.00 |
| Valneva SE (VALN) | France | $0.833B | 0.00 |
| Omeros (OMER) | United States | $0.801B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.795B | 0.00 |
| CeriBell (CBLL) | United States | $0.775B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.589B | 15.95 |
| Verano Holdings (VRNO) | United States | $0.469B | 0.00 |
| Brainsway (BWAY) | Israel | $0.442B | 75.20 |
| Cerus (CERS) | United States | $0.419B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.288B | 0.00 |
| Evolus (EOLS) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| High Tide (HITI) | Canada | $0.213B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.206B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 59.83 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Biote (BTMD) | United States | $0.100B | 4.40 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 30.92 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.032B | 16.30 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |